ISHARES TR - ISHARES BIOTECH (IBB)

CUSIP: 464287556

Q2 2021 13F Holders as of 30 Jun 2021

Share change
-4,543,582
Put/Call ratio
95%
SEC-reported price per share
$163.65
Number of holders
853
Value change
-$736,351,962
Number of buys
358
Open additional details 1 more signal available
Number of sells
322

Security key

464287556

Report period

Q2 2021

Institutions

853

Top holders

10

Ownership snapshot

Top reported holders of IBB - ISHARES TR - ISHARES BIOTECH (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
853
Shares
46,764,551
Rows available
853
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
833
Q2 2021 holders
853
Holder diff
20
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .